ReviewDer Pathologe2018
[TILGen study-immunological targets in patients with breast cancer : Influence of tumor-infiltrating lymphocytes].
R Erber et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ReviewDer Pathologe2018
R Erber et al.PubMed ↗Publisher ↗
No numbers read from the abstract.